Literature DB >> 1090790

Focal sclerosing glomerulonephropathy: a clinicopathologic study.

J A Velosa, J V Donadio, K E Holley.   

Abstract

Forty cases of focal sclerosing glomerulonephropathy with nephrotic syndrome or proteinuria were studied retrospectively in regard to clinical presentation, response to steroid therapy and clinical course, and histopathology of the lesion. Morphologically there was a focal segmental and global sclerosis with subendothelial hyaline deposits, collapse of the capillary loops, intracapillary hyaline material or foam cells, filling and widening of the mesangium with mesangial matrix, focal tubular atrophy, and focal interstitial fibrosis. Thirty-four patients had been treated with prednisone; initial complete remission of the nephrotic syndrome occurred in only 4 patients and partial remission in 10. Nine of these 14 patients had nephrotic relapse or became resistant to steroids. Thirty-three percent of the patients progressed to end-stage renal failure and an additional 25 percent had impairment of renal function after a mean of 8 years from onset. Three patients received kidney allografts, and in two the disease recurred in the transplanted kidney. Focal sclerosing glomerulonephropathy associated with nephrotic syndrome or proteinuria appears to be a clinicopathologic entity characterized by resistance to steroid treatment, frequent progression to end-stage renal disease, and recurrence in the transplanted kidney.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090790

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  Correlation between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephrotic syndrome and in focal sclerosing glomerulonephritis.

Authors:  A Bohle; D Glomb; K E Grund; S Mackensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-25

2.  Focal glomerulosclerosis in children: an Argentinian experience.

Authors:  A Tufro-McReddie; E Alvarez; E Arrizurieta; H Repetto
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

3.  Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.

Authors:  J Velosa; K Miller; A F Michael
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

4.  Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.

Authors:  I Shirato; T Sakai; K Kimura; Y Tomino; W Kriz
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Focal sclerosing glomerulopathy. Risk factors of progression and optimal mode of treatment.

Authors:  P C Chan; K W Chan; I K Cheng; M K Chan
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  American Society of Nephrology Quiz and Questionnaire 2015: Glomerular Diseases.

Authors:  Andrew S Bomback; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-04       Impact factor: 8.237

7.  Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis.

Authors:  Gema Fernandez-Juarez; Javier Villacorta; Gloria Ruiz-Roso; Nayara Panizo; Isabel Martinez-Marín; Helena Marco; Pilar Arrizabalaga; Montserrat Díaz; Vanessa Perez-Gómez; Marco Vaca; Eva Rodríguez; Carmen Cobelo; Loreto Fernandez; Ana Avila; Manuel Praga; Carlos Quereda; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2016-05-24

Review 8.  Therapeutic trials in adult FSGS: lessons learned and the road forward.

Authors:  An S De Vriese; Jack F Wetzels; Richard J Glassock; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nat Rev Nephrol       Date:  2021-05-20       Impact factor: 28.314

9.  Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.